Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9788fabd-46c1-44ff-93b5-885a74c68f03&Preview=1
Date 1/12/2009
Company Name Acclarent
Mailing Address 1525-B O’Brien Drive Menlo Park, CA 94025
Company Description Initially, we are focused on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools – Balloon SinuplastyTM devices. Through the Balloon SinuplastyTM technology and our Relieva® product portfolio we offer ENT patients alternatives to conventional endoscopic surgical approaches. FDA clearances for these devices were completed in 2005 and the products were commercially launched in the US that same year.
Proceeds Purposes Acclarent intends to use the proceeds to continue commercialization of its Balloon Sinuplasty(TM) Technology, as well as on-going investment in product development and clinical studies.
M&A Terms
Venture Investor Johnson & Johnson Development Corporation